Education, research notes, and product intelligence.
Fresh editorial content for peptide research, skincare science, wellbeing categories, Svelta-GPT updates, and research-use product guidance.
Intermittent Fasting Influences Brain-Gut Microbiome Axis in Weight Science
Recent studies reveal intermittent fasting triggers coordinated changes in gut bacteria and brain regions linked to appetite and self-control, suggesting a complex biological dialogue in weight regulation.
UK Regulator Approves Wegovy Weight-Loss Tablets
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Wegovy tablets, a semaglutide-based GLP-1 receptor agonist, for adults meeting specific criteria. This marks the first oral weight-loss pill of its kind authorised in the UK.
Access & Market: Shaping Obesity Prevention Beyond Individual Willpower
Obesity in England reflects broader market forces like pricing, advertising, and access rather than individual willpower alone. Public health policies must prioritise prevention by regulating food markets and limiting industry influence.
Exploring Side-Effects of GLP-1 Weight-Loss Medications
GLP-1 medications like Wegovy and Mounjaro have gained popularity for weight management, but various side-effects have been reported. This article reviews current evidence, distinguishing well-documented effects from emerging or anecdotal claims.
GLP-1 Receptor Agonists and Their Impact on Fat Graft Biology
GLP-1 receptor agonists, widely used for weight management, may influence adipocyte biology in ways that could affect autologous fat graft survival, according to emerging preclinical evidence.
US Panel Recommends Easing Restrictions on Controversial Peptides
A US federal advisory panel has narrowly voted to ease restrictions on peptides popular in wellness circles, despite limited scientific evidence supporting their safety or efficacy.
The Emerging Peptide Market: Legalisation and Industry Readiness
With the FDA panel expected to recommend legal production of several peptides, compounding pharmacies and telehealth companies are preparing for a significant market shift. Despite current legal restrictions, a grey market thrives, highlighting the demand and risks involved. Industry leaders anticipate a multi-billion-dollar opportunity pending regulatory approval.
FDA Advisory Committee Reviews Experimental Peptides Amid Safety Concerns
The FDA’s advisory committee is set to evaluate whether certain experimental peptides should be allowed for compounding in pharmacies, highlighting ongoing debates about safety and regulation.
What Are GLP-1 Receptor Agonists? A Simple Guide to These Popular Weight Loss & Diabetes Drugs
GLP-1 receptor agonists are medicines that mimic a natural hormone to help control appetite and blood sugar. Learn how they work, common examples, and why they’re gaining attention.
What is Cagrilintide? A Simple Guide to This New Weight Loss Treatment
Discover what Cagrilintide is, how it works, and what recent studies say about this once-a-week injection aimed at supporting weight management.
The “Wolverine” Peptide- Exploring the Science Behind BPC-157 & TB-500
Discover the science behind the peptide combination BPC-157 and TB-500, known as the “Wolverine Stack.” Learn how these peptides function in preclinical research, their nickname’s origin, and the importance of quality and responsible sourcing.
The Biggest Mistake on Your Weight Loss Journey: Not Eating Enough
Discover why eating too little can hinder your weight loss goals and how a balanced, protein-rich diet supports healthy, sustainable progress.